You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Interferon Alfa-2a

Showing 1 - 25 of 7,251
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis Trial in Salt Lake City (Pegylated interferon alpha2a)

Not yet recruiting
  • Myelofibrosis
  • Pegylated interferon alpha2a
  • Salt Lake City, Utah
    Huntsman Cancer Institute at the University of Utah
Sep 6, 2022

Breast Tumors Trial in Guangzhou (IFNa-2a)

Completed
  • Breast Neoplasms
  • Guangzhou, Guangdong, China
    Shicheng Su
Feb 8, 2022

HIV Trial in United States (Interferon alfa-2a, Zidovudine, Zalcitabine)

Completed
  • HIV Infections
  • Interferon alfa-2a
  • +2 more
  • Birmingham, Alabama
  • +3 more
Oct 27, 2021

Membranous Nephropathy Trial in Nice (Peginterferon Alfa-2A 180 MCG/ML Injectable Solution)

Not yet recruiting
  • Membranous Nephropathy
  • Peginterferon Alfa-2A 180 MCG/ML Injectable Solution
  • Nice, France
    CHU de NICE
Jul 4, 2023

Essential Thrombocytopenia Trial in Tianjin (Recombinant Interferon Alpha, Pegylated interferon alfa-2b)

Recruiting
  • Essential Thrombocytopenia
  • Recombinant Interferon Alpha
  • Pegylated interferon alfa-2b
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 18, 2022

Advanced Renal Cell Carcinoma Trial in Spain (Pazopanib + interferon alpha 2A)

Completed
  • Advanced Renal Cell Carcinoma
  • Pazopanib + interferon alpha 2A
  • Hospitalet de Llobregat, Barcelona, Spain
  • +12 more
Mar 9, 2022

Hepatitis C Trial in Rotterdam (Peginterferon alfa-2a, Interferon alfa-2a, Ribavirin)

Completed
  • Hepatitis C
  • Peginterferon alfa-2a
  • +2 more
  • Rotterdam, Netherlands
    Erasmus Medical Center
Aug 26, 2021

HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

Recruiting
  • HLA-A2 Positive Cells Present
  • Refractory Melanoma
  • Alpha-type-1 Polarized Dendritic Cells
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 12, 2022

Sarcoma, Kaposi, HIV Trial in New York (Interferon alfa-2a, Zidovudine, Interferon alfa-n1)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Interferon alfa-2a
  • +2 more
  • New York, New York
    Mem Sloan - Kettering Cancer Ctr
Oct 28, 2021

Sarcoma, Kaposi, HIV Trial in Miami (Interferon alfa-2a, Zidovudine, Interferon alfa-n1)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Interferon alfa-2a
  • +2 more
  • Miami, Florida
    Univ of Miami School of Medicine
Oct 27, 2021

Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

Completed
  • Hepatitis C
  • Bradford, United Kingdom
  • +3 more
Jan 4, 2023

Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)

Active, not recruiting
  • Triple -Negative Breast Cancer
  • +4 more
  • Biopsy
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Aug 1, 2022

Colon Cancer Trial in Køge (Pegasys, Saline)

Not yet recruiting
  • Colon Cancer
  • Køge, Zealand, Denmark
    Zealand University Hospital
Jun 14, 2021

Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Buffalo (drug,

Completed
Has Results
  • Metastatic Carcinoma in the Liver
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 25, 2022

HIV, Anus Tumors Trial in Seattle (Isotretinoin, Interferon alfa-2a)

Completed
  • HIV Infections
  • Anus Neoplasms
  • Seattle, Washington
    University of Washington AIDS CRS
Oct 27, 2021

Chronic Hepatitis B Trial in Shanghai (Hepalatide, Placebo of Hepalatide, Tenofovir Alafenamide Tablets)

Not yet recruiting
  • Chronic Hepatitis B
  • Shanghai, Shanghai, China
  • +1 more
Feb 16, 2022

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Best Practice
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 1, 2022

Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +2 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Feb 6, 2023

HIV, Hepatitis B, Hepatitis C Trial (Adefovir dipivoxil, Peginterferon-alfa-2A, Ribavirin)

Withdrawn
  • HIV Infections
  • +2 more
  • Adefovir dipivoxil
  • +3 more
  • (no location specified)
Oct 28, 2021

Chronic Hepatitis B Trial in Amsterdam (Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir

Completed
  • Chronic Hepatitis B
  • Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir disoproxil fumarate
  • Amsterdam, Noord-Holland, Netherlands
    Academic Medical Center
Mar 25, 2021

HIV, Hepatitis C Trial in United States (Ribavirin, Interferon alfa-2a, Peginterferon alfa-2a)

Completed
  • HIV Infections
  • Hepatitis C
  • San Diego, California
  • +23 more
Oct 28, 2021

Chronic Hepatitis B Trial in Worldwide (VIR-2218, pegylated interferon-alfa 2a)

Active, not recruiting
  • Chronic Hepatitis B
  • Birtinya, Queensland, Australia
  • +21 more
Dec 20, 2021

Juvenile Pilocytic Astrocytomas, Optic Pathway Gliomas Trial in Atlanta (Pegylated interferon alpha-2b)

Completed
Has Results
  • Juvenile Pilocytic Astrocytomas
  • Optic Pathway Gliomas
  • Pegylated interferon alpha-2b
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Jan 18, 2022

HIV Trial in United States (Interferon alfa-2a, Zidovudine)

Completed
  • HIV Infections
  • Los Angeles, California
  • +5 more
Oct 26, 2021

Sarcoma, Kaposi, HIV Trial in United States (Interferon alfa-2a, Zidovudine)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Miami, Florida
  • +8 more
Oct 26, 2021